Ozempic economics: How GLP-1s will disrupt the economy in 2025

By The Washington Post
| January 06, 2025

With adult obesity rates falling last year for the first time in more than a decade, drugs such as Ozempic and Zepbound are already reshaping Americans' waistlines. Now, they're poised to reshape the entire economy, too.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...